208 related articles for article (PubMed ID: 20157583)
1. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
Demidenko ZN; Blagosklonny MV
Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin decelerates cellular senescence.
Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
4. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
Demidenko ZN; Blagosklonny MV
Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
[TBL] [Abstract][Full Text] [Related]
5. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
Leontieva OV; Demidenko ZN; Blagosklonny MV
Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
[TBL] [Abstract][Full Text] [Related]
6. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
Leontieva OV; Demidenko ZN; Gudkov AV; Blagosklonny MV
PLoS One; 2011; 6(10):e26126. PubMed ID: 22022534
[TBL] [Abstract][Full Text] [Related]
7. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate.
Romanov VS; Abramova MV; Svetlikova SB; Bykova TV; Zubova SG; Aksenov ND; Fornace AJ; Pospelova TV; Pospelov VA
Cell Cycle; 2010 Oct; 9(19):3945-55. PubMed ID: 20935470
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
Demidenko ZN; Shtutman M; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical suppression of cellular senescence by p53.
Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
[TBL] [Abstract][Full Text] [Related]
12. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
[TBL] [Abstract][Full Text] [Related]
13. Gerosuppression by pan-mTOR inhibitors.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
[TBL] [Abstract][Full Text] [Related]
14. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.
Demidenko ZN; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1901-4. PubMed ID: 19471118
[TBL] [Abstract][Full Text] [Related]
15. The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors.
Blagosklonny MV
Cell Cycle; 2011 Jul; 10(14):2295-8. PubMed ID: 21715978
[TBL] [Abstract][Full Text] [Related]
16. Pseudo-DNA damage response in senescent cells.
Pospelova TV; Demidenko ZN; Bukreeva EI; Pospelov VA; Gudkov AV; Blagosklonny MV
Cell Cycle; 2009 Dec; 8(24):4112-8. PubMed ID: 19946210
[TBL] [Abstract][Full Text] [Related]
17. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
[TBL] [Abstract][Full Text] [Related]
18. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16.
Sung JY; Lee KY; Kim JR; Choi HC
Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827
[TBL] [Abstract][Full Text] [Related]
19. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
[TBL] [Abstract][Full Text] [Related]
20. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
Khor ES; Wong PF
Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]